Gamma Biosciences Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Out of Business
- Financing Rounds
-
2
- Investments
-
9
Gamma Biosciences General Information
Description
Operator of a life sciences platform intended to support the development and manufacturing of advanced biologic therapies. The company offers bioprocessing tools, purification membranes, and real-time process sensors, enabling biopharmaceutical companies to optimize manufacturing efficiency and accelerate the production of cell and gene therapies through specialized technology acquisition and commercial support.
Contact Information
Website
www.gammabiosciences.comCorporate Office
- 2800 Sand Hill Road
- Menlo Park, CA 94025
- United States
Corporate Office
- 2800 Sand Hill Road
- Menlo Park, CA 94025
- United States
Gamma Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Gamma Biosciences Comparisons
Industry
Financing
Details
Gamma Biosciences Competitors (5)
One of Gamma Biosciences’s 5 competitors is Cytiva, a Formerly Accelerator/Incubator backed company based in Marlborough, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cytiva | Formerly Accelerator/Incubator backed | Marlborough, MA | ||||
| Repligen | Corporation | Waltham, MA | ||||
| Pall | Corporate Backed or Acquired | Port Washington, NY | ||||
| Thermo Fisher Scientific | Formerly PE-Backed | Waltham, MA | ||||
| Sartorius | Corporation | Goettingen, Germany |
Gamma Biosciences Signals
Gamma Biosciences Investments (9)
Gamma Biosciences’s most recent deal was a Corporate with Univercells Technologies for . The deal was made on 18-Jun-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Univercells Technologies | 18-Jun-2022 | Corporate | Biotechnology | ||
| Nirrin | 05-Oct-2021 | Early Stage VC | Biotechnology | ||
| Mirus Bio | 18-May-2021 | Buyout/LBO | Biotechnology | ||
| Univercells | 17-Dec-2020 | Later Stage VC | Holding Companies | ||
| Nirrin | 05-May-2020 | Seed Round | Biotechnology |
Gamma Biosciences Exits (5)
Gamma Biosciences’s most recent exit was on 18-Jun-2022 from Univercells Technologies. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Univercells Technologies | 18-Jun-2022 | Completed |
|
||
| Mirus Bio | 18-May-2021 | Completed |
|
||
| Univercells | 17-Dec-2020 | Completed |
|
||
| Astrea Bioseparations | 25-Nov-2019 | Completed |
|
||
| Biotage | 30-Jun-2000 | IPO | Completed |
|
Gamma Biosciences Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| BioMagnetic Solutions | State College, PA | 2012 |
Gamma Biosciences FAQs
-
When was Gamma Biosciences founded?
Gamma Biosciences was founded in 2019.
-
Where is Gamma Biosciences headquartered?
Gamma Biosciences is headquartered in Menlo Park, CA.
-
What is the size of Gamma Biosciences?
Gamma Biosciences has 11 total employees.
-
What industry is Gamma Biosciences in?
Gamma Biosciences’s primary industry is Discovery Tools (Healthcare).
-
Is Gamma Biosciences a private or public company?
Gamma Biosciences is a Private company.
-
What is Gamma Biosciences’s current revenue?
The current revenue for Gamma Biosciences is .
-
Who are Gamma Biosciences’s competitors?
Cytiva, Repligen, Pall, Thermo Fisher Scientific, and Sartorius are competitors of Gamma Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process